Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1632 1651 1683
This examiner grants 51% of resolved cases
Emily Ann Cordas has resolved 553 cases in Tech Center 1600. Her examination history in Art Unit 1632 shows an allowance rate of 50.8 percent. This figure is a primary indicator for applicants to use when evaluating the likelihood of a favorable outcome and for preparing for a potentially challenging prosecution process.
The median days to allowance for this examiner is 1291. This timeframe is essential for practitioners to consider when advising clients on the expected duration of the patenting process. A timeline of 1291 days helps in setting realistic goals for the various stages of prosecution and for budgeting legal expenses over the life of the application.
The interview lift for this examiner is 57.3 percent. This represents a very significant increase over the 50.8 percent allowance rate, indicating that interviews are an exceptionally effective method for resolving issues. The 57.3 percent lift suggests that practitioners should prioritize personal communication with the examiner to clarify technical disagreements and move the application toward a grant.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17611500 | TREATMENT OF ISCHEMIC STROKE WITH APTAMERS TARGETING TLR-4 | Final Rejection | Merck Patent GmbH |
| 18561873 | A METHOD FOR PRODUCING BLOOD PROGENITOR AND PROGENITOR T CELLS, RESULTING CELLS AND METHODS AND USES THEREOF | Non-Final OA | The University of British Columbia |
| 16963023 | METHODS AND COMPOSITIONS FOR INHIBITION OF INNATE IMMUNE RESPONSE ASSOCIATED WITH AAV TRANSDUCTION | Non-Final OA | The University of North Carolina at Chapel Hill |
| 17919677 | CLEARANCE OF SENESCENT CELLS BY ACTIVATION OF iNKT CELLS | Final Rejection | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA |
| 17799851 | Regulating Activation of Fibroblasts to Prevent Fibrosis | Non-Final OA | The Regents of the University of California |
| 18600975 | METHOD FOR EVALUATING MIGRATION ABILITY OF MIGRATORY CELLS | Non-Final OA | TOPPAN HOLDINGS INC. |
| 18561900 | METHODS FOR THE EXPANSION OF HUMAN GRANULOCYTE-MACROPHAGE PROGENITORS AND APPLICATIONS THEREOF | Non-Final OA | University of Southern California |
| 18552262 | NUCLEOTIDE EDITING TO REFRAME DMD TRANSCRIPTS BY BASE EDITING AND PRIME EDITING | Non-Final OA | The Board of Regents of The University of Texas System |
| 17407604 | Cardiac Muscle-Cell-Based Coupled Oscillator Network for Collective Computing and Related Methods | Non-Final OA | University of Virginia Patent Foundation |
| 18546236 | TREATMENT OF AN IOP CONDITION | Non-Final OA | THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK |
| 18684668 | DIRECT REPROGRAMMING OF CELLS INTO CARDIAC PURKINJE-LIKE CELLS USING A UNIVERSAL SMALLMOLECULE COCKTAIL | Non-Final OA | UNIVERSITY OF HOUSTON SYSTEM |
| 18293711 | DESIGNER MEMBRANELESS ORGANELLES SEQUESTER NATIVE FACTORS FOR CONTROL OF CELL BEHAVIOR | Non-Final OA | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA |
| 17777460 | COMPOSITION, COMPRISING COTL1 AS ACTIVE INGREDIENT, FOR DIAGNOSIS OF BONE DISEASE OR OBESITY | Non-Final OA | AJOU UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION |
| 18726671 | Cell Cultivation Methodology | Non-Final OA | Ronawk, Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy